“We started fiscal year 2026 on a strong note, generating over $1 million in revenue – a record for our Company and a significant milestone,” said Harry Simeonidis, President and CEO of Intelligent Bio Solutions (INBS). “As new customer acquisitions accelerate, we are seeing strong momentum in both cartridge and reader sales, with cartridge revenue up approximately 43% year-over-year and reader revenue up approximately 23% year-over-year for the fiscal first quarter. These results represent a substantial improvement on the previous quarter, demonstrating the strength of our business model and positioning us well for continued growth.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Adds 33 New Customer Accounts
- Intelligent Bio Solutions secures 33 customer accounts in Q1
- Intelligent Bio secures major UK contract with industrial service provider
- Intelligent Bio Solutions Approves Incentive Plan Amendment
- Intelligent Bio Solutions Updates FDA Clearance Timeline